ReviewFuture oncology (London, England)2020
Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer.
Carolyn E Haunschild et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this paperpooled itcites it